Morgan Stanley Cocrystal Pharma, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$0.38 - $0.55 $68,289 - $98,840	-179,710 Reduced 25.1%	536,296 $220,000
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.55 $68,289 - $98,840	-179,710 Reduced 25.1%	536,296 $220,000
Q1 2022 Oct 27, 2022	BUY	$0.48 - $0.71 $86,260 - $127,594	179,710 Added 33.51%	716,006 $394,000
Q1 2022 May 13, 2022	BUY	$0.48 - $0.71 $957 - $1,416	1,995 Added 0.28%	716,006 $394,000
Q4 2021 Feb 14, 2022	BUY	$0.65 - $1.02 $3 - $5	5 Added 0.0%	714,011 $464,000
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.25 $721,146 - $892,507	714,006 New	714,006 $750,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.